Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
破解密码：了解分析师对Sage Therapeutics的评论
Throughout the last three months, 17 analysts have evaluated Sage Therapeutics (NASDAQ:SAGE), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，有17位分析师对Sage Therapeutics（纳斯达克股票代码：SAGE）进行了评估，提出了从看涨到看跌的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.76, a high estimate of $29.00, and a low estimate of $8.00. Experiencing a 23.77% decline, the current average is now lower than the previous average price target of $25.92.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为19.76美元，最高估计为29.00美元，低估值为8.00美元。目前的平均价格下降了23.77％，现在低于之前的平均目标股价25.92美元。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The perception of Sage Therapeutics by financial experts is analyzed...
通过分析师最近的行动...
登录免费看全文
登录/注册